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Research paper 
Design of an anti-inflammatory diet (ITIS diet) for patients with 
rheumatoid arthritis 
Marta F. Bustamante a, Meritxall Agustín-Perez a, Francesca Cedola a, Roxana Coras a,c, 
Rekha Narasimhan a, Shahrokh Golshan b, Monica Guma a,c,* 
a Department of Medicine, University of California San Diego, San Diego, CA, USA 
b Department of Psychiatry, University of California San Diego, San Diego, CA, USA 
c Department of Medicine, Autonomous University of Barcelona, Plaça Cívica, 08193, Bellaterra, Barcelona, Spain   
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A B S T R A C T   
Background: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that affects synovial joints, 
leading to inflammation, joint destruction, loss of function, and disability. Although recent pharmaceutical ad-
vances have improved treatment of RA, patients with RA often inquire about dietary interventions to improve RA 
symptoms, as they perceive rapid changes in their symptoms after consumption of certain foods. There is evi-
dence that some ingredients have pro- or anti-inflammatory effects. In addition, recent literature has shown a 
link between diet and microbiome changes. Both diet and the gut microbiome are linked to circulating metab-
olites that may modulate inflammation. However, evidence of the effects of an anti-inflammatory and probiotic- 
rich diet in patients with RA is scarce. There is also a need for biological data to support its anti-inflammatory 
effects. 
Methods: The main goal of this study is to delineate the design process for a diet tailored to our RA population. To 
achieve this goal, we collected information on diet, supplements, cooking methods, and intake of different in-
gredients for each patient. Different groups were interviewed, and their feedback was assessed to design a diet 
that incorporates suggested anti-inflammatory ingredients in a manner that was easy for patients to adopt based 
on their lifestyles and backgrounds. 
Results: We designed a diet that includes a high intake of potential anti-inflammatory ingredients. Feedback from 
highly motivated patients was critical in constructing an anti-inflammatory diet (ITIS diet) with elevated 
adherence. 
Conclusion: In order to tailor our diet, we surveyed our patients on several different parameters. We obtained 
important feedback on how feasible our ITIS diet is for RA patients. Using this feedback, we made minor im-
provements and finalized the design of the ITIS diet. This diet is being used in an on-going pilot study to 
determine their anti-inflammatory effect in pain and joint swelling in RA patients. 
Trial registration: Not applicable.   
1. Background 
Rheumatoid arthritis (RA) is a systemic, debilitating, chronic in-
flammatory autoimmune disorder affecting approximately 1% of the 
world population [1]. RA is a form of arthritis that causes pain, swelling, 
stiffness, and loss of function in joints. This disease severely impacts 
quality of life with increased morbidity and mortality. Although recent 
pharmaceutical advances have improved the treatment of RA, most RA 
patients need lifelong pharmacological therapy. RA patients often seek 
additional sources of relief and/or treatments with less side effects, and 
often inquire about dietary interventions to improve RA symptoms, as 
they perceive rapid changes in pain and/or swelling after consumption 
of certain foods [2]. However, rheumatologists lack information to 
advise RA patients on nutrition. 
Diet might modulate RA symptoms by influencing the patient’s 
metabolic profile and increasing antioxidant levels, but also by altering 
the microflora of the intestine. The gut microbiome is incredibly dy-
namic and can change rapidly to dietary perturbations [3]. In addition, 
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the gut microbiome is also involved in the metabolism of some dietary 
components and has the potential to modify circulating pro- or 
anti-inflammatory mediators [4]. For example, trimethylamine-N-oxide, 
a pro-inflammatory metabolite that derives from choline and carnitine 
present in red meat, eggs, and dairy products, is produced by Prevotella 
copri among other bacteria [5,6]. An increased abundance of Prevotella 
copri was found in new-onset untreated RA patients suggesting P. copri 
may be pathogenic [7]. In general, bacteria that have an almost exclu-
sive saccharolytic metabolism, such as lactobacilli and bifidobacterial, 
are considered potentially beneficial [8]. Both gut microbial species 
produce a variety of tryptophan catabolites which are critical for in-
testinal homeostasis by decreasing intestinal permeability [9]. In addi-
tion, some of these catabolites enter the bloodstream and have 
anti-inflammatory and anti-oxidative effects [9]. Various dietary com-
ponents including miso and yogurt are a source of this beneficial flora. 
Daily yogurt was shown to reduce biomarkers of chronic inflammation 
in premenopausal women [10]. Dietary fiber, other complex carbohy-
drates, and sugar alcohols present in fruits are prebiotics and might also 
be beneficial by supporting healthy microbiome [11,12]. For instance, 
microbial degradation of whole-grain complex carbohydrates increases 
short chain fatty acids (SCFA), which were shown to be beneficial to 
intestinal immune response [13]. 
In addition, several foods have been identified as pro-inflammatory, 
including highly refined flours, gluten [14], trans- and saturated-fatty 
acids (FA) [15–17], dairy products (milk and cheeses) [18], and red 
meat [19,20]. Some vegetables such as tomatoes, eggplants, and po-
tatoes contain solanine, a glycoalkaloid, which was suggested to in-
crease intestinal permeability and be detrimental for arthritogenic 
pathologies [21–26]. In contrast, other nutrients have been suggested to 
offer numerous health benefits [27], including long chain omega-3 
polyunsaturated FA (PUFA) (chia seeds, flaxseeds, fatty fish) [28–32], 
monounsaturated FA (MUFA) (avocado, sesame) [33,34], antioxidants 
[35], phytochemicals [36], flavonoids [37,38], vitamin D [39], fruits 
with enzymatic proteins such as papain and bromelain (papaya, mango, 
pineapple) [40–42], ginger [43], turmeric [44,45], black pepper [46, 
47], green tea [48–50], and legumes [46,51]. However, only a few 
randomized double-blind placebo-controlled clinical trials have 
attempted to determine whether supplementation with these in-
gredients [31,34,35,37,38,43] or probiotics [52,53] are beneficial in RA 
patients. So far, most of the studies are pilot studies with small number 
of patients, studies on animal models, or in vitro studies. 
Despite a large number of publications on the effect of different in-
gredients and gut microbiome on inflammation, and reports showing an 
association between poor dietary quality and inflammation in RA pa-
tients [54,55], only a few interventional studies have investigated 
whether specific diet improves RA symptoms (for review [56,57]). The 
effects of complete diet intervention (including vegetarian and Medi-
terranean diets) have shown positive effects in ameliorating RA symp-
toms. One of the studies showed that fasting first and then eating a 
vegetarian diet for one year was beneficial in RA, particularly in terms of 
number of swollen joints, stiffness, and C reactive protein (CRP) [58]. A 
diet trial with Mediterranean diet (MD) also showed a decrease in dis-
ease activity (DAS28) of 0.56 (p < 0.001) and in quality of life compared 
to control diet [59]. Yet, we could not find a trial using a diet that in-
corporates and combines different potential anti-inflammatory 
ingredients. 
Here, we will describe the steps taken to design our anti- 
inflammatory diet (ITIS diet) for a complementary therapy in RA pa-
tients. In Table 1, we summarized the strategies and ingredients 
included in the ITIS diet. This diet is an omnivorous diet, based on a 
Mediterranean diet but with several modifications. Our diet reinforces 
fast digestions by dissociating grains from proteins, suggests certain 
cooking methods [60], is a diet low on gluten, and also includes enzy-
matic fruits, whole grains, a very high consumption of omega 3 PUFA 
and MUFA, and anti-inflammatory dressings and spices. It introduces 
green juices in the morning to increase green leafy vegetables and fruit 
Table 1 
Strategies and recommendations in the ITIS diet.  
Main recommendations 
(WHAT/WHAT FOR) 
Based on (WHY) Diet strategies (HOW)  
 Lower the omega6/3 
PUFA ratio to 2:1  
 Increase intake of 
MUFA  
 Decrease intake of pro- 
inflammatory FA such 
as trans-FA and satu-
rated FA (present in 
dairy products, red 
meat and processed 
food)  
 A low omega 6/3 PUFA 
ratio reduces 
inflammation and 
improves 
autoimmunity 
symptoms [28–32].  
 MUFA found in nuts, 
avocado, sesame and 
olive oil have beneficial 
effect in RA [33,34]  
 Industrially produced 
trans-FA increase in-
flammatory markers 
and saturated FA in-
crease inflammation 
[15–17].  
 The diet must contain 
fatty fish such as 
sardines, tuna, twice 
per week, daily intake 
of chia seeds and 
flaxseed oil.  
 Daily intake of nuts, 
avocado, and/or 
sesame seeds or tahini  
 Avoid pre-cooked 
food, red meat and 
processed meat. Cook 
by baking, boiling or 
vapor. Avoid frying for 
long periods since it 
modifies PUFA to 
trans-FA [60].  
 High intake of 
prebiotics  
 Daily intake of 
probiotics  
 Dietary fiber, whole- 
grain complex carbo-
hydrates, and sugar al-
cohols present in fruits 
are prebiotics that sup-
port healthy micro-
biome [11,12] and 
increases SCFA produc-
tion improving immu-
nity [13].  
 Probiotics including 
yogurt reduce the levels 
of the pro- 
inflammatory cytokines 
and improves disease 
activity in RA [10,52, 
53]  
 Daily green leafy 
vegetables (arugula, 
lettuce, broccoli, 
zucchini, Green beans) 
and fruits (prebiotic 
source).  
 Daily home-made 
green juice (made of 
fruits and green vege-
tables) (prebiotic 
source).  
 Promote whole grains 
and avoid refined 
flours (prebiotic 
source).  
 Daily yogurt (a brand 
that contains 
Lactobacillus Casei 
among other species 
(Chobani) and miso 
(probiotic source).  
 Help digestion of large 
proteins in the gut and 
avoid unnecessary 
fermentation  
 Fiber consumption and 
enzymatic fruits will 
reduce colonic transit, 
and will help protein 
digestion  
 Bromelain and papain 
were shown to have an 
anti-inflammatory ef-
fect as well [40–42].  
 Large proteins in dairy 
products are not 
completely digested 
and can feed 
proteolytic bacteria, 
resulting in the 
production of pro- 
inflammatory metabo-
lites [66].  
 Daily enzymatic fruit: 
pineapple, mango or 
papaya (source of 
bromelain, papain and 
other proteolytic 
enzymes)  
 Disassociate 
consumption of 
proteins from grains  
 Increase fiber intake  
 Substitute plant-based 
milks (almond, rice, 
coconut) for dairy.  
 Condiment with anti- 
inflammatory spices  
 Eliminate salt  
 Turmeric, black pepper 
and ginger have 
antioxidant and anti- 
inflammatory actions 
[43–46]  
 Black pepper increases 
bioavailability of 
curcuma [46,47]  
 High salt intake is 
associated with the risk 
of arthritis and has 
been related to 
autoimmunity [67,68].  
 Condiment with 
turmeric, black pepper 
and ginger.  
 Turmeric and black 
pepper should be used 
at the same time.  
 Low salt intake by 
eliminating precooked 
food  
 Substitute vegetables 
with potential anti- 
inflammatory  
 Solanaceae vegetables 
contain glycoalkaloids. 
Glycoalkaloids have 
been reported to affect  
 Avoid the consumption 
of eggplant, tomatoes 
and potatoes and 
increase consumption 
(continued on next page) 
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consumption, and daily yogurt and miso as probiotic. It also avoids 
consumption of processed and red meat, caffeine, dairy products (except 
yogurt), and vegetables from the solanaceae family. Of note, not all the 
ingredients and strategies proposed in our ITIS diet are based on inter-
ventional diet studies in RA patients. We wanted to introduce in-
gredients suggested to be beneficial in animal models or other 
inflammatory diseases as well. Therefore, the design of this diet is 
intended to give an alternative to non-vegetarian population with higher 
content of potential anti-inflammatory ingredients than the typical 
Mediterranean diet. 
2. Methods 
Patients: Thirty-four adult patients with RA fulfilling the 2010 ACR/ 
EULAR classification criteria for RA, were recruited from the Arthritis 
Clinics at the University of California at San Diego (UCSD). The study 
was approved by the UCSD Institutional Review Board. We recruited 
patients from the two most prevalent populations in our Arthritis 
Clinics: Hispanic and Caucasian RA patients. For one year, we worked 
with a total of 20 Hispanic and 14 Caucasian RA patients in collabora-
tion with a nutritionist to put together a 14-day ITIS diet that was 
feasible and that included our proposed anti-inflammatory/probiotic 
components (Table 1). 
Initial design of the diet: In order to design this first draft, we 
examined the bibliography relating ingredients and inflammation, and 
diet intervention in RA patient. Once we decided the strategies and in-
gredients we wanted to introduce, we designed a Mediterranean-based 
7-day draft diet, which also included the main strategies described in 
Table 1, and was structured as followed: daily green juices in the 
morning, 3 main meals and 2 snacks. 
Diet modifications with RA patients was conducted in four 
phases: Since our main goal was to design a feasible diet, we worked 
with several small groups of patients to tailor the diet for higher 
adherence. The information gathered in the four phases of the study 
contributed to modify the draft until we built the final diet and in-
structions. Different patients were recruited for each phase. In Phase I, 
we evaluated the dietary habits of each patient in the last year in order to 
gather information about their current diet habits. In Phase II, we 
gathered information about patient knowledge, accessibility, afford-
ability, and taste preferences of our proposed ingredients. In phase III, 
we designed a first draft of the diet with patient instructions and asked 
for patient feedback to assess how accurately patients were able to un-
derstand and follow the diet. In phase IV, we conducted a 7-day trial 
with patient feedback for final adjustments on the diet (Fig. 1). Macro 
and micro-nutrient composition as well as more details of our ITIS diet is 
available for interested parties. 
3. Results 
3.1. Phase I 
A representative sample of 5 Hispanic and 5 Caucasian patients were 
included in this phase. We constructed and distributed a diet habit 
questionnaire (Additional file 1) in order to elucidate dietary habits of 
the patients in the last year. The questionnaire contained questions 
about how frequently (how many times per week) our patients had 
Table 1 (continued ) 
Main recommendations 
(WHAT/WHAT FOR) 
Based on (WHY) Diet strategies (HOW) 
properties for sol-
anaceae vegetables 
intestinal permeability 
[21–26]  
 Vegetables with high 
content of 
phytochemicals were 
suggested to have anti- 
inflammatory proper-
ties (garlic, onion, 
pumpkin, zucchini, 
carrot, green leafy veg-
etables) [36] 
of garlic, onion, carrot, 
pumpkin, zucchini or 
green leafy vegetables.  
 Decrease consumption 
of red meat.  
 It contains high levels 
of choline, which is the 
precursor of the 
inflammatory 
metabolite TMAO [5,6] 
and saturated FA.  
 Introduce legumes 
(red, white beans, 
lentils or garbanzo), 
poultry and white fish, 
2–3 days a week each. 
Avoid red meat.  
 Reduce consumption 
of gluten  
 Gluten has been 
associated with 
inflammatory states 
[14].  
 Pseudocereals and 
whole grains reduce 
inflammation [69,70]  
 Substitute whole 
grains such as rye, 
corn, oats or quinoa for 
refined wheat.  
 Avoid sugars, sugary 
foods and sugary 
beverages  
 Sugary foods and 
beverages are 
associated to obesity, 
microbiome changes 
and low-grade inflam-
matory state [71].  
 Substitute honey for 
sugar. Avoid soda and 
juices.  
 Substitute green tea for 
coffee  
 Green tea contains 
polyphenols which 
decrease pro- 
inflammatory cytokines 
in animal models and in 
vitro models of RA) 
[48–50,72,73]  
 Some studies suggest 
that coffee 
consumption may 
increase the risk of 
developing RA [74].  
 Daily green tea  
 Increase the intake of 
antioxidants, 
phytochemicals 
vitamins and 
flavonoids  
 Antioxidants, 
phytochemicals, 
flavonoids and 
vitamins were 
suggested to have anti- 
inflammatory proper-
ties [35–39].  
 Vegetables, fruits, 
apple cider vinegar, 
whole grains contain 
high amounts of 
antioxidants, 
phytochemicals 
vitamins, and 
flavonoids.  
 Daily home-made 
green juice (made of 
fruits and green 
vegetables)  
Fig. 1. Flow chart showing the different phases of the design of the ITIS diet. 
From a draft that included potential anti-inflammatory ingredients described in 
the scientific literature, in phase I, we got information of current dietary habits, 
in phase II, we collected information about the ingredients that we wanted to 
include, in phase III, we requested feedback about the instructions and strate-
gies of our ITIS diet, and in phase IV, a few patients followed the ITIS diet for 7 
days. The continuous feedback from our patients helped us make adjustments to 
the diet and build our final version of the ITIS diet. 
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consumed meat, eggs, fish, bread, grains, vegetables, mushrooms, le-
gumes, nuts, fruits, sauces, sweets, snacks, soups, and dairy products in 
the last year. In addition, patients were asked about their drinking habits 
and food preparation practices, including time invested in cooking. The 
questionnaire took approximately 1 h to complete, and RA patients filled 
the questionnaires individually in a designated room at the clinical 
facilities. 
Average frequency of consumption of the ingredients (times per 
week) of these 10 RA patients are shown in additional file 2. Patient 
consumption of vegetables, fruits, meat, eggs, fish, grains, legumes and 
nuts did not differ from our ITIS diet. Of note, red meat was consumed 
less than once a week among these RA patients. Leeks, onion, peppers, 
and lettuce were the most consumed vegetables; berries and avocados 
were the most consumed fruits followed by peaches, nectarines, apri-
cots, oranges, apples, and pears. Enzymatic fruits and ginger were not 
frequently consumed. Alcohol consumption was low, but they had daily 
coffee. Patients also reported a high consumption of simple carbohy-
drates such as cookies and cakes, added sugar, and consumed dairy 
products almost daily. They did consume yogurt but not miso. They did 
not frequently add seeds, anti-inflammatory dressings or anti- 
inflammatory spices in their food. They used olive oil followed by 
canola oil. Patients mainly steamed or boiled their food, but also fried 
for longer than 5 min. Though patients mainly prepared their meals at 
home, pre-cooked food was used frequently. 
3.2. Phase II 
A total of 6 Hispanic and 5 Caucasian patients were included in this 
phase. The objective of this phase was to gather information about pa-
tient knowledge and assess the affordability and accessibility of the 
products included in the ITIS diet. We designed a questionnaire that 
assessed the following categories: familiarity with ingredients, previous 
consumption of ingredients, knowledge of food and preparation 
methods, knowledge of where to buy the ingredients, and affordability 
of the ingredients. The questionnaire took around 30 min to complete 
and RA patients answered it individually in a designated room at the 
clinical facilities. 
After the questionnaire was administered, we assigned a numeric 
value based on patient responses: if the response was negative, we 
assigned 0. If the response was positive, we assigned 100, and if it was 
doubtful, we assigned 50. Finally, we averaged patient responses for 
each ingredient and analyzed feasibility of patient use. Responses 
regarding patient knowledge and accessibility to consumption were 
averaged for individual ingredients (Additional file 3). We also calcu-
lated two final scores: accessibility was calculated as the average of the 
following questions: ‘do you know where to buy it?’, ‘can you buy it near 
your home?’, ‘do you know the price?’ and ‘can you afford it?’. Knowl-
edge was calculated as the average of the following questions: ‘do you 
know what it is?’, ‘do you consume it?’ and ‘do you know how to cook 
it?’. If final averages fell below 50 for any category, this was interpreted 
as poor knowledge or accessibility for that ingredient, and we recon-
sidered introducing the ingredient and/or reevaluated our strategy for 
introducing the ingredient. 
Additional file 3 shows the results of this questionnaire. Most of the 
ingredients that we intended to include in our ITIS diet were well-known 
and easily accepted. All of the fruits, most vegetables, chicken, and nuts, 
were well-known and accessible. Of note, knowledge and accessibility 
correlated well for each product; this possibly reflects a relationship 
between knowing how to use an ingredient and knowing where to buy it 
at the best price. Notably, products that have been promoted recently in 
the media, such as ginger and chia seeds, were well-known and acces-
sible to patients. 
Several ingredients had a value of <50 in knowledge or accessibility. 
These ingredients were: rye, tahini, kefir, arugula, turmeric, quinoa, 
miso, tofu, flaxseed oil, omelets, apple cider vinegar, and sweet potato. 
Among the ingredients that were poorly accepted, we decided to 
completely remove kefir, and substituted it with yogurt. Other in-
gredients such as rye (contained in german bread), sweet potato, arugula 
shoots, quinoa, apple cider vinegar, and tofu were made optional (but 
recommended). Ingredient that we deemed critical were left as a 
mandatory ingredient in the ITIS diet: miso, turmeric, flaxseed oil, and 
tahini. 
We also asked patients if they were willing to avoid some products 
and/or substitute them for others. Of the patients surveyed, one did not 
respond to this question, and 9 out of 10 patients agreed to substitute: 
refined cereals for integral cereals, solanaceae vegetables for green 
vegetables, trans fatty acids and saturated fatty acids for omega 3 PUFA 
and MUFA, sugar for stevia or honey, soda drinks for home-made juices, 
and dairy products for vegetable extracts. 8 out of 10 patients were 
willing to substitute alcoholic drinks and coffee for green tea, and 6 out 
of 10 patients agreed to reduce gluten consumption. 
Finally, patients were asked if they had access to a blender to 
determine if they were able to prepare smoothies. All Hispanic patients 
and 3 of the 4 Caucasian patients had one available at home. Average 
available time to cook per day was 1.5 h (1.03), with a range from 30 
min to 3 h. All but one patient responded that they were willing to learn 
new recipes, and subjects assigned themselves an average of 8.6/10 in 
their resolution to follow the diet. 
3.3. Phase III 
9 Hispanic and 6 Caucasian patients were included in phase III. We 
asked patients for feedback on a final version of the 14-day diet (which 
included both the diet and pertinent instructions). We focused on 
whether the diet could be easily understood and completed by patients. 
Patients were shown the diet and instructions, and after providing 
necessary clarifications, we asked patients to answer the diet-related 
questions shown in additional file 4A. Patients responded individually 
in a designated room at the clinical facilities. 
The feedback from this phase is shown in additional file 4B. All pa-
tients understood the instructions and overall were not worried about 
satiety and time to prepare the meals. When patients were asked about 
the diet schedule, all but 3 indicated that they could adhere to it. 12 
patients reported that they would be satiated with the diet, while three 
patients expressed doubt. We also observed that most patients had suf-
ficient time to prepare breakfast correctly. Though most of the ques-
tioned patients did not indicate their cooking habits, those who did, 
indicated that they often steam, bake, or grill. We did encounter a few 
complaints on certain aspects of the diet plan. Some patients complained 
about elimination of dairy products, coffee, and alcohol. Yet, we 
strongly believe that these products would detrimentally affect inflam-
mation and decided to eliminate them from the 14-day diet. We sug-
gested substituting dairy products with nut extracts like almond milk, 
and coffee with green tea. Finally, patients asked for more recipe ex-
amples to facilitate diet completion. 
3.4. Phase IV 
We conducted a pilot trial of a 7-day ITIS diet on 5 Hispanic and 3 
Caucasian patients in order to get their feedback about following the 
diet. Patients were provided with turmeric, black pepper, powder 
ginger, flaxseed oil, apple vinegar, tahini, sesame seeds, miso, chai 
seeds, flaxseeds, rye bread, oatmeal, almond milk, and olive oil to 
facilitate their consumption. We had 1-h session with groups of two to 
three patients to explain the diet and instructions in detail. Sessions were 
conducted in English or Spanish depending on patient preferences. Pa-
tients were instructed to keep a diet diary and were given instructions on 
how to contact us in case of questions. 
We obtained feedback from 4 Hispanic patients; one patient dropped 
out of the trial. All 3 Caucasian patients completed the 7-diet trial. The 
Hispanic patients surveyed, except for some exceptions attributed to 
personal tastes, were able to follow the diet and had no critical 
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difficulties. Among Caucasian patients, two patients asked for a shop-
ping list to help with the menu and struggled to accomplish the timings 
and the cooking expectations for the diet. We plan to give more flexi-
bility in the diet schedule for the interventional study. 
Final diet design: Table 2 shows the final version of the ITIS diet. 
For lunch and dinner, three recommended options were given, and pa-
tients were able to distribute those throughout the week. These options 
and guidelines for the patient are described in additional file 5. Macro 
and micro-nutrient composition as well as more details of our ITIS diet is 
available to interested parties. 
4. Discussion 
Though there is some evidence that several foods might be pro- 
inflammatory while other foods might have anti-inflammatory proper-
ties, there are few interventional studies to show their effect in patients 
affected with diseases whose main symptoms are pain and swelling such 
as RA. Although Mediterranean and vegetarian diets are beneficial for 
those suffering from RA, these diets do not include several ingredients 
shown to be anti-inflammatory in some randomized clinical trials or 
animal models of arthritis or in vitro experiments. Given the complexity 
and severity of RA, it seems doubtful that a single change in diet, by 
adding or eliminating one ingredient, would be sufficient to diminish 
systemic inflammation. Some metanalyses of individual ingredients or 
probiotics in RA reflect contradictory results or mild effects of those 
supplements [44,45,61,62]. Instead, a diet that combines several of the 
suggested strategies to decrease inflammation may represent a more 
realistic dietician approach for those suffering from the disease. Yet, the 
patients might adhere better to a small change or addition of just sup-
plements than a complete change in their diet. Thus, our goal was to 
design a diet that introduced patient’s feedback to increase their 
adherence and feasibility for a future interventional trial. 
Patient feedback in the different phases helped us adjust the diet 
based on knowledge and accessibility of ingredients, and to improve the 
quality of the instructions. In phase I, we learned that the strategies our 
ITIS diet contemplated did not differ drastically from the current diet 
habits of our patients. Our patients mentioned that they had adjusted 
their habits since they had been diagnosed, either after getting infor-
mation from nutrition websites, or eliminating some foods they thought 
were triggering their symptoms. We hope that this will increase the 
patient adherence to the ITIS diet. Of note, one study showed an asso-
ciation between specific foods and symptoms in RA patients, and they 
reported that blueberries, fish, and spinach improved RA symptoms, 
while soda containing sugar and desserts aggravated their symptoms 
[2]. 
In phase II, we collected patient feedback about the ingredients that 
were part of the ITIS diet. To increase the feasibility of our diets, the 
ingredients that were poorly known or too expensive were either 
removed, made optional, given more information or provided. Inter-
estingly, some studies have suggested that low socio-economic status 
has been associated with increased RA morbidity, poorer clinical out-
comes, decreased functional ability and reduced quality of life [63]. 
Although people from lower socio-economic are more likely to smoke, 
which is a known environmental risk factor for RA, they are also more 
deficient in certain micronutrients. Of interest, a study from Harvard 
School of Public Health found that eating a healthy diet (rich in fruits, 
vegetables, fish, and nuts) cost about $1.50 more per day per person 
than eating an unhealthy diet (the kind full of processed foods and 
refined grains) [64]. In phase III, we received feedback about our diet 
instructions and guideline, and we improved the text for clarity and 
included more recipes. Finally, in phase IV, a 7-day feasibility trial 
helped us with the last version of our ITIS diet. Overall, patients were 
highly motivated and open to trying most of the suggested ingredients. 
Managing chronic diseases in self-motivated patients with diet and 
lifestyle changes was shown to be critical to achieve treatment goals in 
other diseases [65]. 
The strength of this study is the continuous feedback we got from the 
community we are planning to treat to build our ITIS diet. Although we 
expected differences between Hispanic and Caucasian patients given 
their different socioeconomic status, lifestyle, and accessibility to some 
stores, our perception was that the diet habits of Hispanic and Caucasian 
patients were very similar. Additionally, both Caucasians and Hispanics 
had similar knowledge about ingredients included in the diet. Unfortu-
nately, we were unable to conduct statistical analyses given the small 
Table 2 
Final version of the ITIS diet.    
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
7–8 am SMOOTHIE Coconut milk, 
mango, papaya, 
pineapple 
Pear, lemon, 
yogurt, vanilla, 
water 
Grapes, celery, 
spinach, 
cucumber, lime, 
water 
Almond or oat milk, 
spinach, 
strawberries, pear, 
ginger, chia seeds, 
cinnamon 
Spinach, ginger, 
turmeric, 
papaya, 
flaxseeds, 
banana, water 
Papaya, spinach, 
almond milk, 
turmeric, chia 
seeds, honey 
Parsley, 
pineapple, 
strawberries, 
water 
7–8 am BREAKFAST 1-2 spoonful of oats 
with non-dairy 
milk (oat milk, 
almond milk or rice 
milk). Add berries 
(optional).  
Green tea infusion. 
1-2 corn tortillas, 
spread with 
avocado, sesame 
seeds, and flaxseed 
oil.  
Green tea infusion. 
1 -2 corn tortillas 
with tahini 
(sesame seed 
extract) with ¼ 
teaspoon of 
honey.  
Green tea 
infusion 
1-2 spoons of oat 
with non-dairy milk 
(oat, almond or rice 
milk. Add berries 
(optional).  
Green tea infusion. 
1-2 corn 
tortillas, spread 
with avocado, 
sesame seeds, 
and flaxseed oil.  
Green tea 
infusion. 
1 -2 corn tortillas 
with tahini 
(sesame seed 
extract) with ¼ 
teaspoon of 
honey.  
Green tea 
infusion 
1-2 corn tortillas, 
spread with 
avocado, sesame 
seeds, and 
linseed oil.  
Green tea 
infusion. 
10–11 
a.m. 
SNACK Plain yogurt 
(Chobani Brand, no 
sugar added) 
Plain yogurt 
(Chobani Brand, no 
sugar added) 
Plain yogurt 
(Chobani Brand, 
no sugar added) 
Plain yogurt 
(Chobani Brand, no 
sugar added) 
Plain yogurt 
(Chobani Brand, 
no sugar added) 
Plain yogurt 
(Chobani Brand, no 
sugar added) 
Plain yogurt 
(Chobani 
Brand, no 
sugar added) 
12-1 
pm 
LUNCH OPTION 1: Salad (generous plate) 
OPTION 2: Grains with vegetables 
OPTION 3: Legumes with vegetables 
4 p.m. SNACK Mango, papaya, 
pineapple, apple, 
pear or banana 4 
walnuts 
Mango, 
papaya, 
pineapple, 
apple, pear or 
banana 4 
walnuts 
Mango, papaya, 
pineapple, apple, 
pear or banana 4 
walnuts 
Mango, papaya, 
pineapple, apple, 
pear or banana 4 
walnuts 
Mango, papaya, 
pineapple, 
apple, pear or 
banana 4 
walnuts 
Mango, papaya, 
pineapple, apple, 
pear or banana 
4 walnuts 
Mango, papaya, 
pineapple, apple, 
pear or banana 
4 walnuts 
6–7 
pm 
DINNER OPTION 1: Vegetable soup/cream  protein 
OPTION 2: Miso soup  baked/steamed/grilled vegetables  protein 
OPTION 3: Salad  protein  
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number or patients in each phase. Second, we provided groceries. Par-
ticipants received around $100 in specific ingredients that help their 
consumption. Finally, we also provided detailed instructions and dietary 
counseling for the participants at the phase IV which together with 
groceries being provided increased adherence and positive feedback in 
this pilot phase. This diet is being used in an on-going pilot study to 
determine their anti-inflammatory effect in pain and joint swelling in RA 
patients. 
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